Altis Biosystems

Altis Biosystems

Our RepliGut® Systems recreate the human intestinal epithelium in vitro enabling researchers to characterize intestinal toxicity risk earlier, leading to better prediction of safety profiles. RepliGut® Systems derive from human primary stem cells capable of differentiating into key cell-types in the gut epithelium for testing off-target damage to the intestine. Our ethically sourced biobank of stem cells consists of many donors and regions and is available to set up in house or as a service.

2017

ADME (Absorption/Distribution/Metabolism/Excretion), Acute Toxicology Services/Testing, Biotechnology Products, Biotechnology Research/Testing, CRO—Contract Research Organization, High Throughput Test Systems, In Vitro Research/Testing, Preclinical Research/Testing, Research